Worth Asset Management LLC Buys 9,946 Shares of SPDR S&P Biotech ETF $XBI

Worth Asset Management LLC increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 285.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,431 shares of the exchange traded fund’s stock after purchasing an additional 9,946 shares during the period. SPDR S&P Biotech ETF makes up 0.7% of Worth Asset Management LLC’s investment portfolio, making the stock its 26th largest holding. Worth Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $2,125,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Axiom Investment Management LLC purchased a new stake in SPDR S&P Biotech ETF in the first quarter worth approximately $26,000. Financial Life Planners bought a new stake in SPDR S&P Biotech ETF in the 1st quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $30,000. Finally, SHP Wealth Management bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $31,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $157.37 on Friday. SPDR S&P Biotech ETF has a one year low of $84.81 and a one year high of $165.71. The firm has a market capitalization of $10.28 billion, a P/E ratio of 11.47 and a beta of 0.83. The business has a fifty day moving average of $148.00 and a 200 day moving average of $135.33.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.